discussion-presentation45

• Prolactinomas exhibit varying degrees of responsiveness to the class of dopamine agonists, ranging from complete response at one end of the spectrum to total resistance at the other.
• Prolactinomas may respond poorly or incompletely to one dopamine agonist, but well to another.
• Discordant responses to prolactin-lowering and tumor size-reducing effects may be present